Role of insulin in Alzheimer's disease: Approaches emerging from basic animal research and neurocognitive studies in humans

Drug Development Research

Volumn 56, Issue 3, 2002, Pages 511-525

  Kern, Werner ^a   Born, Jan ^a   Fehm, Horst L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Amyloid; Event related brain potentials; Frontal negative slow wave; Insulin degrading enzyme; Intranasal drug delivery; Memory; Selective attention; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; INSULIN; INSULINASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; EVENT RELATED POTENTIAL; HORMONE ACTION; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INFORMATION PROCESSING; INSULIN METABOLISM; LEARNING; MEMORY; NEUROPATHOLOGY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TASK PERFORMANCE;

EID: 0036660007     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10101     Document Type: Review

References (157)

1. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639.
2. Aungst BJ, Rogers NJ, Shefter E. 1988. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 244:23-27.
3. Baker H, Spencer RF. 1986. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res 63:461-473.
4. Balin BJ, Broadwell RD, Salcman M, El-Kalliny M. 1986. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 251:260-280.
5. Banks WA, Jaspan JB, Kastin AJ. 1997. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18:1257-1262.
6. Barnett EM, Perlman S. 1993. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185-191.
7. Barthold SW. 1988. Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta neuropath 76:502-506.
8. Baskin DG, Woods SC, West DB, Van Houten M, Posner BI, Dorsa DM, Porte D Jr. 1983. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology 113:1818-1825.
9. Baskin DG, Figlewicz DP, Woods SC, Porte D Jr, Dorsa DM. 1987. Insulin in the brain. Annu Rev Psychol 49:334-347.
10. Baskin DG, Sipols AJ, Schwartz MW, White MF. 1993. Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine. Regul Pept 48:257-266.
11. Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF. 1994. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 134:1952-1955.
12. Baura GD, Foster DM, Porte D Jr, Kalm SE, Bergman RN, Cobelli C, Schwartz MW 1993. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. J Clin Invest 92:1824-1830.
13. Baura GD, Foster DM, Kaiyala K, Porte D Jr, Kahn SE, Schwartz MW. 1996. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45:86-90.
14. Bhattacharya SK, Saraswati M. 1991. Effect of intracerebroventricularly administered insulin on brain monoamines and acetylcholine in euglycaemic and alloxan-induced hyperglycaemic rats. Indian J Exp Biol 29:1095-1100.
15. Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. 1996. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45:1259-1266.
16. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. 1998. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800:125-135.
17. Birbaumer N, Roberts LE, Lutzenberger W, Rockstroh B, Elbert T. 1992. Area-specific self-regulation of slow cortical potentials on the sagittal midline and its effects on behaviour. Electroenceph Clin Neurophysiol 84:353-361.
18. Born J, Fehm-Wolfsdorf G, Voigt KH, Fehm HL. 1987. Influences of ACTH 4-10 on event-related potentials reflecting attention in man. Physiol Behav 39:83-87.
19. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. 2002. Sniffing neuropeptides-a transnasal approach to the human brain. Nat Neurosci 5:514-516.
20. Boyd FT, Clarke DW, Muther TF, Raizada MK. 1985. Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brian. J Biol Chem 260:15880-15884.
21. Boyt AA, Taddei TK, Hallmayer J, Helmerhorst E, Gandy SE, Craft S, Martins RN. 2000. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience 95:727-734.
22. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099.
23. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125.
24. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95-130.
25. Carbone KM, Duchala CS, Griffin JW, Kincaid AL, Narayan O. 1987. Pathogenesis of Borna disease in rats: evidence that intraaxonal spread is the major route for virus dissemination and the determinant for disease incubation. J Virol 61:3431-3440.
26. Caudle RM. 1993. The demonstration of long latency potentials in the CA1 region of the rat hippocampal slice. Brain Res 613:247-250.
27. Chabot C, Massicotte G, Milot M, Trudeau F, Gagne J. 1997. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res 768:249-256.
28. Chavez M, Kaiyala K, Madden LJ, Schwartz MW, Woods SC. 1995. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 109:528-531.
29. Christie JM, Wenthold RJ, Monaghan DT. 1999. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J Neurochem 72:1523-1528.
30. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T. 1999. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5:560-564.
31. Craft S, Zallen G, Baker L. 1992. Glucose and memory in mild senile dementia of the Alzheimer type. J Clin Exp Neuropsychol 14:253.
32. Craft S, Dagogo-Jack S, Wiethop B, Murphy CM, Nevins R, Fleischman S, Rice V, Newcomer J, Cryer PE. 1993. The effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 107:223.
33. Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. 1996. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17:123-130.
34. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. 1998. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease. Neurology 50:164-168.
35. Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier M, Lofgreen C, LaTendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veith RC. 1999. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56:1135-1140.
36. Craft S, Asthana S, Schellenberg G, Baker L, Cherrier M, Boyt AA, Martins RN, Raskind M, Peskind E, Plymate S. 2000. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann NY Acad Sci 903:222-228.
37. Crone C. 1965. Facilitated transfer of glucose from blood into brain tissue. J Physiol (Lond) 181:103-113.
38. Donchin E. 1981. Surprise...surprise? Psychophysiology 18:493.
39. Doyle P, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. 1995. Fourday hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilisation in specific brain nuclei of freely moving rats. Brain Res 684:47-55.
40. Duelli R, Schrock H, Kuschinsky W, Hoyer S. 1994. Intracerebro-ventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737-743.
41. Duffy KR, Pardridge WM. 1987. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 420:32-38.
42. Durkin TP, Messier C, De Boer P, Westerink BHC. 1992. Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: an in vivo microdialysis study in the rat. Behav Brain Res 49:181.
43. Evans J, Hastings L. 1992. Accumulation of Cd(II) in the CNS depending on the route of administration: intraperitoneal, intratracheal, or intranasal. Fundam Appl Toxicol 19:275-278.
44. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J. 2001. The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 86:1144-1148.
45. Figlewicz DP, Szot P. 1991. Insulin stimulates membrane phospholipid metabolism by enhancing endogenous alpha1-adrenergic activity in the rat hippocampus. Brain Res 550:101-107.
46. Figlewicz DP, Szot P, Greenwood MRC. 1990. Insulin stimulates inositol incorporation in hippocampus of lean but not obese Zucker rats. Physiol Behav 47:325-330.
47. Figlewicz DP, Brot MD, McCall AL, Szot P. 1996. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res 736:54-60.
48. Flood JF, Mooradian AD, Morley JE. 1990. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 39:1391-1398.
49. Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P. 1998. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105:423-438.
50. Frolich L, Blum-Degen D, Riederer P, Hoyer S. 1999. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann NY Acad Sci 893:290-293.
51. Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H. 2001. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21:2561-2570.
52. Gerbrandt LK, Lawrence JC, Eckardt MJ, LLoyd RL. 1978. Origin of the neocortically monitored theta rhythm in the curarized rat. Electroenceph Clin Neurophysiol 45:454-467.
53. Gizurarson S, Thorvaldsson T, Sigurdsson P, Gunnarsson E. 1996. Selective delivery of insulin into the brain: intraolfactory absorption. Int J Pharm 140:77-83.
54. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. 1992. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8:159-168.
55. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR. 2000. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20.
56. Hajnal A, Pothos EN, Lenard L, Hoebel BG. 1998. Effects of feeding and insulin on extracellular acetylcholine in the amygdala of freely moving rats. Brain Res 785:41-48.
57. Halgren E, Squires NK, Wilson CL, Rohrbaugh JW, Babb TL, Crandall PH. 1980. Endogenous potentials generated in the hippocampal formation and amygdala by infrequent events. Science 210:803-805.
58. Hastings L, Evans JE. 1991. Olfactory primary neurons as a route of entry for toxic agents into the CNS. Neurotoxicology 12:707-714.
59. Henneberg N, Hoyer S. 1994. Short-term or long-term intracerebroventricular (i.e.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett 175:153-156.
60. Hong M, Lee VMY. 1997. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547.
61. Hoyer S. 1998. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415-422.
62. Hoyer S, Nitsch R, Oesterreich K. 1991. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect 3:1-14.
63. Illum L. 2000. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1-18.
64. Illum L, Davis SS. 1992. Intranasal insulin. Clinical pharmacokinetics. Clin Pharmacokinet 23:30-41.
65. Izumi Y, Pinard E, Roussel S, Seylaz J. 1992. Insulin protects brain tissue against focal ischemia in rats. Neurosci Lett 144:121-123.
66. Jay TM, Witter MP. 1991. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313:574-586.
67. Jewett DL, Romano MN, Williston JS. 1970. Human auditory evoked potentials: possible brainstem components detected on the scalp. Science 94:681-696.
68. Johanson CE, Murphy VA. 1990. Acetazolamide and insulin alter choroid plexus epithelial cell (Na), pH and volume. Am J Physiol 258:F1538-F1546.
69. Kamal A, Biessels GJ, Urban IJ, Gispen WH. 1999. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression Neuroscience 90:737-745.
70. Kamal A, Biessels GJ, Duis SE, Gispen WH. 2000. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 43:500-506.
71. Karis D, Fabiani M, Donchin E. 1984. "P300" and memory: individual differences in the von Restorff effect. Cogn Psychol 16:177-216.
72. Kern W, Lieb K, Kerner W, Born J, Fehm HL. 1990. Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes 39:1091-1098.
73. Kern W, Kerner W, Pietrowsky R, Fehm HL, Born J. 1994a. Effects of insulin and hypoglycemia on the auditory brainstem response in humans. J Neurophysiol 72:678-683.
74. Kern W, Schlosser C, Kerner W, Pietrowsky R, Born J, Fehm HL. 1994b. Evidence for effects of insulin on sensory processing in man. Diabetes 43:351-356.
75. Kern W, Schiefer B, Schwarzenburg J, Stange EF, Born J, Fehm HL. 1997. Evidence for central nervous effects of corticotropin-releasing-hormone on gastric acid secretion in humans. Neuroendocrinology 65:291-298.
76. Kern W, Born J, Schreiber H, Fehm HL. 1999. Central nervous system effects of intranasally administered insulin during euglycemia in humans. Diabetes 48:557-563.
77. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. 2001. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74:270-280.
78. Lafay F, Coulon P, Astic L, Saucier D, Riche D, Holley A, Flamand A. 1991. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183:320-330.
79. Lang W, Lang M, Podreka I, Steiner M, Uhl F, Suess E, Müller Ch, Deecke L. 1988. DC-potential shifts and regional blood flow reveal frontal cortex involvement in human visuomotor learning. Exp Brain Res 71:353-364.
80. Lannert H, Hoyer S. 1998. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199-1208.
81. Lesort M, Johnson GV. 2000. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience 99:305-316.
82. Lesort M, Jope RS, Johnson GV. 1999. Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72:576-584.
83. Lezak MD. 1993. Neuropsychological assessment. New York: Oxford University Press.
84. Liu L, Brown JC, Webster W, Morisett RA, Monaghan DT. 1995. Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neurosci Lett 192:5-8.
85. Lobmann R, Smid HG, Pottag G, Wagner K, Heinze HJ, Lehnert H. 2000. Impairment and recovery of elementary cognitive function induced by hypoglycemia in type-1 diabetic patients and healthy controls. J Clin Endocrinol Metab 85:2758-2766.
86. Long JM, Davis BJ, Garofalo P, Spangler EL, Ingram DK. 1992. Complex maze performance in young and aged rats: response to glucose treatment and relationship to blood insulin and glucose. Physiol Behav 51:411-418.
87. Lucignani G, Namba H, Nehlig A, Porrino LJ, Kennedy C, Solioloff L, 1987. Effects of insulin on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 7:309-314.
88. Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ, 1999. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10:117-139.
89. Malinow R, Mainen ZF, Hayashi Y. 2000. LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol 10:352-357.
90. Manning C, Ragozzino M, Gold PE. 1993. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer type. Neurobiol Aging 14:523.
91. Marfaing P, Penicaud L, Broer Y, Mraovitch S, Calando Y, Picon L. 1990. Effect of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats. Neurosci Lett 115:279.
92. Masters BA, Shemer J, Judkins JH, Clarke DW, LeRoith D, Raizada MK. 1987. Insulin receptors and insulin action in dissociated brain cells. Brain Res 417:247-256.
93. Mayer G, Nitsch R, Hoyer S. 1990. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 532:95-100.
94. McEwen B, 1988. Glucocorticoid receptors in the brain. Hosp Prac 23:107-121.
95. Mecklinger A, Kramer AF, Strayer DL. 1992. Event related potentials and EEG components in a semantic memory search task. Psychophysiology 29:104-119.
96. Meneilly GS, Hill A. 1993. Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr Soc 41:710-714.
97. Messier C, Destrade C. 1994. Insulin attenuates scopolamine-induced memory deficits. Psychobiology 22:16-21.
98. Messier C, White NM. 1987. Memory improvement by glucose, fructose, and two glucose analogs: a possible effect on peripheral glucose transport. Behav Neural Biol 48:104-127.
99. Mochizuki A, Tamaoka A, Shimohata A, Komatsuzaki Y, Shoji S. 2000. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355:42-43.
100. Morales JA, Herzog S, Kompter C, Frese K, Rott R. 1988. Axonal transport of Borna disease virus along olfactory pathways in spontaneously and experimentally infected rats. Med Microbiol Immunol Berl 177:51-68.
101. Näätänen R. 1982. Processing negativity: an evoked-potential reflection of selective attention. Psychol Bull 92:605-640.
102. Näätänen R, Picton TW. 1987. The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology 24:375-425.
103. Okada YC, Kaufman L, Williamson SJ. 1983. The hippocampal formation as a source of the slow endogenous potentials. Electroenceph Clin Neurophysiol 55:417-426.
104. Okita T, Wijers AA, Mulder G, Mulder LJM. 1985. Memory search and visual spatial attention: an event related brain potential analysis. Acta Psychol 60:263-292.
105. Oliver EH, Sartin JL, Dieberg G, Rahe CH, Marple DN, Kemppainen BJ. 1989. Effects of acute insulin deficiency on catecholamine and indolamine content and catecholamine turnover in microdissected hypothalamic nuclei in streptozotocin-diabetic rats. Acta Endocrinol (Copenh) 120:343-350.
106. Palovcik RA, Philiphs MI, Kappy MS, Raizada MK. 1984. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res 309:187-191.
107. Park CR. 2001. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25:311-323.
108. Park CR, Seeley RJ, Craft S, Woods SC. 2000. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68:509-514.
109. Peinado JM, Meyers BD. 1991, Norepinephrine release from PVN and lateral hypothalamus during perfusion with 2-DG or insulin in the sated and fasted rat. Pharmacol Biochem Behav 27:715-721.
110. Pelosi L, Hayward M, Blumhardt LD. 1998. Which event-related potentials reflect memory processing in a digit-probe identification task? Cogn Brain Res 6:205-218.
111. Perez A, Morelli L, Cresto JC, Castano EM. 2000. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res 25:247-255.
112. Perl DP, Good PF. 1987. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet i:1028.
113. Perlman S, Evans C, Afifi A. 1990. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 172:1127-1132.
114. Picton TW, Hillyard SA, Krausz HI, Calambos R. 1974. Human auditory evoked potentials. I. Evaluation of components. Electroencephalogr Clin Neurophysiol 36:179-190.
115. Pietrowsky R, Born J, Kern W, Fehm HL. 1996a. Functional evidence for a transmission of peptides along the olfactory systems into the brain in healthy humans. In: Krisch B, Mentlein R, editors. The peptidergic neuron. Basel: Birkhäuser. p 291-296.
116. Pietrowsky R, Thiemann A, Kern W, Fehm HL, Born J. 1996b. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 21:559-572.
117. Plaschke K, Hoyer S. 1993. Action of the diabetogenic drug streptozotocin on glycolytic metabolism in adult brain and hippocampus. Int J Dev Neurosci 11:477-483.
118. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid betaprotein by degradation. J Biol Chem 273:32730-32738.
119. Redding EK. 1967. Modification of sensory cortical evoked potentials by hippocampal stimulation. Electroenceph Clin Neurophysiol 22:74-83.
120. Rockstroh B, Elbert T, Canavan AGMT, Lutzenberger W, Birbaumer N. 1989, Slow cortical potentials. München: Urban and Schwarzenberg.
121. Ruchkin DS, Johnson R Jr, Mahaffey D, Sutton S. 1988. Towards a functional categorization of slow waves. Psychophysiology 25:339-353.
122. Sakane T, Akizuki M, Yoshida M, Yamashita S, Nadai T, Hashida M, Sezaki H. 1991. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J Pharm Pharmacol 43:449-451.
123. Santucci AC, Schroeder H, Riccio DC. 1990. Homeostatic disruption and memory: effect of insulin administration in rats. Behav Neural Biol 53:321-333.
124. Schwartz MW, Sipols AJ, Kahn SE, Lattemann DP, Taborsky G Jr, Bergman BN, Woods SC, Porte D Jr. 1990. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 259:E378-E383.
125. Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ, Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D Jr. 1991. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. J Clin Invest 88:1272-1281.
126. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. 1992. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387-413.
127. Seabrook GR, Rosahl TW. 1999. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 38:1-17.
128. Seki T, Sato N, Hasegawa T, Kawaguchi T, Juni K. 1994. Nasal absorption of zidovudine and its transport to cerebrospinal fluid. Biol Pharm Bull 17:1135-1137.
129. Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B. 1992. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol 66:992-998.
130. Shapiro E, Brown SD, Saltiel AR, Schwartz JH. 1991. Short-term action of insulin on Aplysia neurons: generation of a possible novel modulator of ion channels. J Neurobiol 22:55-62.
131. Shibata S, Liou SY, Ueki S, Oomura Y. 1985. Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparation. Physiol Behav 36:79-81.
132. Shinba T, Andow Y, Shinozaki T, Ozawa N, Yamamoto K. 1996. Event-related potentials in the dorsal hippocampus of rats during an auditory discrimination task. Electroenceph Clin Neurophysiol 100:563-568.
133. Shiosaka S. 1999. Attempts to make models for Alzheimer's disease. Neurosci Res 13:237.
134. Sigurdsson P, Thorvaldsson T, Gizurarson S. 1997. Olfactory absorption of insulin to the brain. Drug Deliv 4:195-200.
135. Smid HGOM, Trümper BG, Pottag G, Wagner K, Lobmann R, Scheieh H, Lehnert H, Heinze H-J. 1997. Differentiation of hypoglycemia induced cognitive impairments. Brain 120:1041-1056.
136. Squire LR. 1992. Memory and the hippocampus: a synthesis of findings with rats, monkeys and humans. Psychol Rev 99:195.
137. Steffens AB, Scheurink AJ, Porte D Jr, Woods SC. 1988. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Physiol 255:R200-R204.
138. Stewart M. 1993. Disinhibition of hippocampal pyramidal cells during the transition into theta rhythm. Exp Brain Res 93:1-5.
139. Stone WS, Cotrill KL, Walker DL, Gold PE. 1988. Blood glucose and brain function: interactions with CNS cholinergic systems. Behav Neural Biol 50:325.
140. Stortebecker P. 1989. Mercury poisoning from dental amalgam through a direct nose-brain transport [Letter]. Lancet 1:1207-1207.
141. Tallroth G, Lindgren M, Stenberg G, Rosen I, Agardh CD. 1990. Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type I (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 33:319-323.
142. Tamburrano G, Lala A, Locuratolo N, Leonetti F, Sbraccia P, Giaccari A, Busco S, Porcu S, 1988. Electroencephalography and visually evoked potentials during moderate hypoglycemia. J Clin Endocrinol Metabol 66:1301-1306.
143. Tarkka IM, Stokic DS, Basile LF, Papnicolaou AC. 1995. Electric source localization of the auditory P300 agrees with magnetic source localization. Electroenceph Clin Neurophysiol 96:538-545.
144. Taylor SF, Kornblum S, Lauber EJ, Minoshima S, Koeppe RA. 1997. Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage 6:81-92.
145. Unger JW, Livingston JN, Moss AM. 1991. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36:343-362.
146. Van Hoesen GW, Macdougall JM, Mitchell JC. 1975. Some connections of the entorinal (area 28) and perirhinal (area 35) cortices of the Rhesus monkey. II. Frontal lobe afferents. Brain Res 95:25-38.
147. Van Houten M, Posner BI. 1983. Circumventricular organs: receptors and mediators of direct peptide hormone action on brain. Adv Metab Disord 10:269-289.
148. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ. 2000. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20:1657-1665.
149. Vinogradova OS. 1999. The hippocampus and the orienting reflex. In: Sokolov EN, Vinogradova OS, editors, Neuronal mechanisms of the orienting reflex. Hilsdale: Erlbaum. p 128-154.
150. Wallace WC, Akar CA, Lyons WE, Kole HK, Egan JM, Wolozin B. 1997. Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res Mol Brain Res 52:213-227.
151. Wallum BJ, Porte D Jr, Figlewicz DP, Jacobson L, Dorsa D. 1987. Cerebrospinal fluid insulin levels increase during intravenous insulin infusion in man. J Clin Endocrinol Metab 64:190-194.
152. Wan Q, Xiong ZG, Man HY, Ackerley CA, Braunton J, Lu WU, Becker LE, MacDonald JF, Wang YT. 1997. Recruitment of functional GABA(A) receptors to postsynptic domains by insulin. Nature 388:686-690.
153. Watanabe Y, Matsumoto Y, Kawamoto K, Yazawa S, Matsumoto M. 1992. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits. Chem Pharm Bull 40:3100-3104.
154. Wickelgren I. 1998. Tracking insulin to the mind. Science 280:517-1519.
155. Woods SC, Figlewicz Lattemann DP, Schwartz MW, Porte D Jr. 1990. A re-assessment of the regulation of adiposity and appetite by the brain insulin system. Int J Obes 14(Suppl 3):69-73.
156. Zhao WQ, Alkon DL. 2001. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177:125-134.
157. Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL. 1999. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem 274:34893-34902.